Adli M - Search Results

1

A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3).

Ricken R, Wiethoff K, Reinhold T, Stamm TJ, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Laux G, Hauth I, Möller HJ, Heinz A, Bauer M, Adli M. Ricken R, et al. Among authors: adli m. J Affect Disord. 2018 Mar 1;228:173-177. doi: 10.1016/j.jad.2017.11.051. Epub 2017 Nov 13. J Affect Disord. 2018. PMID: 29253683

2

[Lithium in the treatment of acute depression].

Adli M, Bschor T, Canata B, Döpfmer S, Bauer M. Adli M, et al. Fortschr Neurol Psychiatr. 1998 Oct;66(10):435-41. doi: 10.1055/s-2007-995282. Fortschr Neurol Psychiatr. 1998. PMID: 9825248 Review. German.

3

[Olanzapine in the treatment of depressive disorders with psychotic symptoms].

Adli M, Rossius W, Bauer M. Adli M, et al. Nervenarzt. 1999 Jan;70(1):68-71. doi: 10.1007/s001150050402. Nervenarzt. 1999. PMID: 10087520 German.

4

How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.

Bschor T, Berghöfer A, Ströhle A, Kunz D, Adli M, Müller-Oerlinghausen B, Bauer M. Bschor T, et al. Among authors: adli m. J Clin Psychopharmacol. 2002 Aug;22(4):427-30. doi: 10.1097/00004714-200208000-00016. J Clin Psychopharmacol. 2002. PMID: 12172345 Clinical Trial.

5

Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study.

Adli M, Berghöfer A, Linden M, Helmchen H, Müller-Oerlinghausen B, Mackert A, Stamm T, Bauer M. Adli M, et al. J Clin Psychiatry. 2002 Sep;63(9):782-90. doi: 10.4088/jcp.v63n0906. J Clin Psychiatry. 2002. PMID: 12363118 Clinical Trial.

6

Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders.

Bauer M, Berghöfer A, Bschor T, Baumgartner A, Kiesslinger U, Hellweg R, Adli M, Baethge C, Müller-Oerlinghausen B. Bauer M, et al. Among authors: adli m. Neuropsychopharmacology. 2002 Oct;27(4):620-8. doi: 10.1016/S0893-133X(02)00320-2. Neuropsychopharmacology. 2002. PMID: 12377398 Clinical Trial.

7

Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.

Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M. Bschor T, et al. Among authors: adli m. Depress Anxiety. 2003;17(1):43-8. doi: 10.1002/da.10078. Depress Anxiety. 2003. PMID: 12577277 Clinical Trial.

8

Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression.

Bschor T, Baethge C, Adli M, Lewitzka U, Eichmann U, Bauer M. Bschor T, et al. Among authors: adli m. J Psychiatry Neurosci. 2003 May;28(3):210-6. J Psychiatry Neurosci. 2003. PMID: 12790161 Free PMC article.

9

Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder.

Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M. Bschor T, et al. Among authors: adli m. J Psychiatr Res. 2003 Mar-Apr;37(2):135-43. doi: 10.1016/s0022-3956(02)00088-2. J Psychiatr Res. 2003. PMID: 12842167 Clinical Trial.

10

Lithium augmentation therapy in refractory depression-update 2002.

Bauer M, Forsthoff A, Baethge C, Adli M, Berghöfer A, Döpfmer S, Bschor T. Bauer M, et al. Among authors: adli m. Eur Arch Psychiatry Clin Neurosci. 2003 Jun;253(3):132-9. doi: 10.1007/s00406-003-0430-9. Eur Arch Psychiatry Clin Neurosci. 2003. PMID: 12904977 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page